Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders

IF 0.9 Q4 HEMATOLOGY Hemato Pub Date : 2023-06-14 DOI:10.3390/hemato4020015
G. Pratt, H. Giles, J. Pinney
{"title":"Renal Disorders Associated with Waldenström Macroglobulinaemia, IgM MGUS and IgM-Producing B-Cell Lymphoproliferative Disorders","authors":"G. Pratt, H. Giles, J. Pinney","doi":"10.3390/hemato4020015","DOIUrl":null,"url":null,"abstract":"Renal disorders are uncommonly associated with IgM MGUS and Waldenström macroglobulinaemia (WM). Data are limited to large case series that suggest that related renal involvement occurs in 5% of patients with WM. Although uncommon, there is a much greater variety of renal pathologies associated with WM and IgM MGUS than that seen in patients with multiple myeloma, where cast nephropathy predominates. In WM, uncommonly direct infiltration of the renal system by lymphoma or cast nephropathy with a high light-chain level can occur. AL amyloidosis can present with nephrotic syndrome as a feature with IgM MGUS or WM. Cryoglobulinaemia and light-chain deposition disease are other important potential causes of renal impairment with IgM MGUS and WM. There are other rarer monoclonal gammopathy of renal significance (MGRS) conditions characterised by typically isolated kidney disease that are causally related to a B-cell or plasma-cell clonal disorder usually in a precancerous MGUS state, although in some renal pathologies, the association is less clear. Central to the majority of these diagnoses is the need for an accurate renal histological diagnosis, and management requires close joint working of renal and haematology teams.","PeriodicalId":93705,"journal":{"name":"Hemato","volume":"1 1","pages":""},"PeriodicalIF":0.9000,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemato","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/hemato4020015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Renal disorders are uncommonly associated with IgM MGUS and Waldenström macroglobulinaemia (WM). Data are limited to large case series that suggest that related renal involvement occurs in 5% of patients with WM. Although uncommon, there is a much greater variety of renal pathologies associated with WM and IgM MGUS than that seen in patients with multiple myeloma, where cast nephropathy predominates. In WM, uncommonly direct infiltration of the renal system by lymphoma or cast nephropathy with a high light-chain level can occur. AL amyloidosis can present with nephrotic syndrome as a feature with IgM MGUS or WM. Cryoglobulinaemia and light-chain deposition disease are other important potential causes of renal impairment with IgM MGUS and WM. There are other rarer monoclonal gammopathy of renal significance (MGRS) conditions characterised by typically isolated kidney disease that are causally related to a B-cell or plasma-cell clonal disorder usually in a precancerous MGUS state, although in some renal pathologies, the association is less clear. Central to the majority of these diagnoses is the need for an accurate renal histological diagnosis, and management requires close joint working of renal and haematology teams.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
与Waldenström巨球蛋白血症、IgM MGUS和产生IgM的b细胞淋巴细胞增生性疾病相关的肾脏疾病
肾脏疾病与IgM MGUS和Waldenström巨球蛋白血症(WM)罕见相关。数据仅限于大型病例系列,表明5%的WM患者发生了相关的肾脏受累。尽管不常见,但与多发性骨髓瘤患者相比,WM和IgM-MGUS相关的肾脏病理种类要多得多,在多发性骨瘤患者中,铸态肾病占主导地位。在WM中,淋巴瘤或具有高轻链水平的铸造肾病可发生罕见的肾系统直接浸润。AL淀粉样变性可作为IgM-MGUS或WM的特征表现为肾病综合征。冷球蛋白血症和轻链沉积病是IgM-MGUS和WM肾损害的其他重要潜在原因。还有其他罕见的具有肾脏意义的单克隆gammopathy(MGRS)疾病,其特征是典型的孤立性肾脏疾病,与B细胞或浆细胞克隆性疾病有因果关系,通常处于MGUS癌前状态,尽管在一些肾脏病理中,这种关系不太清楚。大多数诊断的核心是需要准确的肾脏组织学诊断,管理需要肾脏和血液学团队的密切合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.30
自引率
0.00%
发文量
0
审稿时长
11 weeks
期刊最新文献
The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax. Synthetic Lethality Approaches in Acute Lymphoblastic Leukemia Hemato Keeps You Updated on the Research in Hematology The Role of Platelet Molecules in Risk Stratification of Patients with COVID-19 Fibril-Forming Organelles in Mesangial Cells in Renal Biopsies from Patients with Light-Chain-Associated Amyloidosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1